NanoViricides, Inc. Reports that its Drug Candidates Demonstrated Significant Inhibition of Herpes Virus Infection

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reports that it has filed its financial year end annual report (Form 10K) with the Securities and Exchange Commission (SEC) yesterday in a timely manner. The report can be accessed at the SEC website (http://www.sec.gov/Archives/edgar/data/1379006/000114036110041099/form10k.htm).
MORE ON THIS TOPIC